Mesa Laboratories MLAB Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Efficiency | |||||
| Asset turnover | 0.6×0.0× | 0.5×— | —— | —— | |
| Liquidity | |||||
| Current ratio | 1.7×+1.1× | 0.6×-1.8× | 2.5×— | —— | |
| Leverage | |||||
| Debt-to-equity | 0.4×-0.6× | 1×+1.0× | 0×— | —— | |
| Valuation | |||||
| Market capitalization | $542.27M+3.7% | $644.75M+9.0% | $591.77M-37.0% | $938.65M-30.2% | |
| Price / sales | 2.2×0.0× | 2.7×-0.1× | 2.7×-1.5× | 4.3×-3.0× | |
| Price / book | 2.9×-0.4× | 4×0.0× | 4.1×+1.7× | 2.4×— | |
| Dividend yield | 0.6%0.0pp | 0.5%0.0pp | 0.6%+0.2pp | 0.4%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Mesa Laboratories's profit margins?
- Mesa Laboratories (MLAB) runs a 56.8% gross margin and a 2.3% operating margin, with a 1.5% net margin.
- Where do Mesa Laboratories's ratios come from?
- Every ratio is computed from Mesa Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
